These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 28367447)

  • 1. Association between Parathyroid Hormone, 25 (OH) Vitamin D, and Chronic Kidney Disease: A Population-Based Study.
    Wang WH; Chen LW; Lee CC; Sun CY; Shyu YC; Hsu HR; Chien RN; Wu IW
    Biomed Res Int; 2017; 2017():7435657. PubMed ID: 28367447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D status and its association with mineral and bone disorder in a multi-ethnic chronic kidney disease population.
    Ngai M; Lin V; Wong HC; Vathsala A; How P
    Clin Nephrol; 2014 Oct; 82(4):231-9. PubMed ID: 25161115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elderly patients with chronic kidney disease have higher risk of hyperparathyroidism.
    Elias RM; Moysés RMA
    Int Urol Nephrol; 2017 Oct; 49(10):1815-1821. PubMed ID: 28695313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of renal function on vitamin D metabolism in the very elderly.
    Van Pottelbergh G; Matheï C; Vaes B; Adriaensen W; Gruson D; Degryse JM
    J Nutr Health Aging; 2013 Feb; 17(2):107-11. PubMed ID: 23364486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low.
    Ennis JL; Worcester EM; Coe FL; Sprague SM
    J Nephrol; 2016 Feb; 29(1):63-70. PubMed ID: 25736620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study.
    Hjelmesaeth J; Hofsø D; Aasheim ET; Jenssen T; Moan J; Hager H; Røislien J; Bollerslev J
    Cardiovasc Diabetol; 2009 Feb; 8():7. PubMed ID: 19187564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between circulating levels of 25(OH) vitamin D and parathyroid hormone in chronic kidney disease: quest for a threshold.
    Metzger M; Houillier P; Gauci C; Haymann JP; Flamant M; Thervet E; Boffa JJ; Vrtovsnik F; Froissart M; Stengel B; Ureña-Torres P;
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2922-8. PubMed ID: 23633202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of High vs. Conventional Ergocalciferol Dose for Increasing 25-Hydroxyvitamin D and Suppressing Parathyroid Hormone Levels in Stage III-IV CKD with Vitamin D Deficiency/Insufficiency: A Randomized Controlled Trial.
    Thimachai P; Supasyndh O; Chaiprasert A; Satirapoj B
    J Med Assoc Thai; 2015 Jul; 98(7):643-8. PubMed ID: 26267985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?
    Anderson JL; Vanwoerkom RC; Horne BD; Bair TL; May HT; Lappé DL; Muhlestein JB
    Am Heart J; 2011 Aug; 162(2):331-339.e2. PubMed ID: 21835295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical value of two methods to measure parathyroid hormone in chronic renal insufficiency, considering vitamin D metabolism].
    Kovács L; Virágh E; Balogh D; Kálmán B; Lőcsei Z; Toldy E
    Orv Hetil; 2013 Dec; 154(51):2025-36. PubMed ID: 24334134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
    Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study.
    Molina P; Górriz JL; Molina MD; Peris A; Beltrán S; Kanter J; Escudero V; Romero R; Pallardó LM
    Nephrol Dial Transplant; 2014 Jan; 29(1):97-109. PubMed ID: 23975842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Intact PTH and Bio-Intact PTH Assays Among Non-Dialysis Dependent Chronic Kidney Disease Patients.
    Einbinder Y; Benchetrit S; Golan E; Zitman-Gal T
    Ann Lab Med; 2017 Sep; 37(5):381-387. PubMed ID: 28643486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-sectional analysis of abnormalities of mineral homeostasis, vitamin D and parathyroid hormone in a cohort of pre-dialysis patients. The chronic renal impairment in Birmingham (CRIB) study.
    Zehnder D; Landray MJ; Wheeler DC; Fraser W; Blackwell L; Nuttall S; Hughes SV; Townend J; Ferro C; Baigent C; Hewison M
    Nephron Clin Pract; 2007; 107(3):c109-16. PubMed ID: 17890873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor-23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease.
    Parker VJ; Harjes LM; Dembek K; Young GS; Chew DJ; Toribio RE
    J Vet Intern Med; 2017 May; 31(3):791-798. PubMed ID: 28186657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D and parathyroid hormone status in community-dwelling elderly patients with mild-to-moderate kidney impairment.
    Charoenngam N; Sriussadaporn S
    Int Urol Nephrol; 2021 May; 53(5):973-983. PubMed ID: 33420892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are low plasma levels of 25-(OH)vitamin D a major risk factor for hyperparathyroidism independent of calcitriol in renal transplant patients?
    Lomonte C; Antonelli M; Vernaglione L; Cazzato F; Casucci F; Chimienti D; Bruno A; Cocola S; Verrelli EA; Basile C
    J Nephrol; 2005; 18(1):96-101. PubMed ID: 15772930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D.
    Vieth R; Ladak Y; Walfish PG
    J Clin Endocrinol Metab; 2003 Jan; 88(1):185-91. PubMed ID: 12519850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease.
    Taal MW; Thurston V; McIntyre NJ; Fluck RJ; McIntyre CW
    Kidney Int; 2014 Aug; 86(2):407-13. PubMed ID: 24429404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.